Relmada Therapeutics Stock Forecast

Buy or Hold candidate since Jun 29, 2026 Loss -0.86%

The Relmada Therapeutics, Inc. stock price fell by -0.86% on the last day (Tuesday, 30th Jun 2026) from $6.98 to $6.92. During the last trading day the stock fluctuated 4.50% from a day low at $6.79 to a day high of $7.09. The price has risen in 6 of the last 10 days and is up by 8.63% over the past 2 weeks. Volume has increased on the last day by 37 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $16.06 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.99% during the next 3 months and, with a 90% probability hold a price between $4.97 and $6.64 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

RLMD Signals & Forecast

The Relmada Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $6.74 and $6.78. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -0.86%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Relmada Therapeutics, Inc. stock

Relmada Therapeutics, Inc. finds support from accumulated volume at $6.73 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.305 between high and low, or 4.50%. For the last week, the stock has had daily average volatility of 6.89%.

Our recommended stop-loss: $6.71 (-3.03%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (RLMD) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Relmada Therapeutics, Inc. to open at $6.93, and during the day (based on 14 day Average True Range), to move between $6.71 and $7.13, which gives a possible trading interval of +/-$0.419 (+/-6.25%) up or down from last closing price. If Relmada Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.25% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $7.03 (1.59%) than the support at $6.73 (2.75%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Relmada Therapeutics, Inc. stock A Buy?

Relmada Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: -0.481 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 1, 2026 - $6.93 ( 0.169%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk